• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期复苏方案对脓毒症和低血压成年患者院内死亡率的影响:一项随机临床试验

Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial.

作者信息

Andrews Ben, Semler Matthew W, Muchemwa Levy, Kelly Paul, Lakhi Shabir, Heimburger Douglas C, Mabula Chileshe, Bwalya Mwango, Bernard Gordon R

机构信息

Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee.

Department of Internal Medicine, School of Medicine, University of Zambia, Lusaka.

出版信息

JAMA. 2017 Oct 3;318(13):1233-1240. doi: 10.1001/jama.2017.10913.

DOI:10.1001/jama.2017.10913
PMID:28973227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5710318/
Abstract

IMPORTANCE

The effect of an early resuscitation protocol on sepsis outcomes in developing countries remains unknown.

OBJECTIVE

To determine whether an early resuscitation protocol with administration of intravenous fluids, vasopressors, and blood transfusion decreases mortality among Zambian adults with sepsis and hypotension compared with usual care.

DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 212 adults with sepsis (suspected infection plus ≥2 systemic inflammatory response syndrome criteria) and hypotension (systolic blood pressure ≤90 mm Hg or mean arterial pressure ≤65 mm Hg) presenting to the emergency department at a 1500-bed referral hospital in Zambia between October 22, 2012, and November 11, 2013. Data collection concluded December 9, 2013.

INTERVENTIONS

Patients were randomized 1:1 to either (1) an early resuscitation protocol for sepsis (n = 107) that included intravenous fluid bolus administration with monitoring of jugular venous pressure, respiratory rate, and arterial oxygen saturation and treatment with vasopressors targeting mean arterial pressure (≥65 mm Hg) and blood transfusion (for patients with a hemoglobin level <7 g/dL) or (2) usual care (n = 105) in which treating clinicians determined hemodynamic management.

MAIN OUTCOMES AND MEASURES

The primary outcome was in-hospital mortality and the secondary outcomes included the volume of intravenous fluid received and receipt of vasopressors.

RESULTS

Among 212 patients randomized to receive either the sepsis protocol or usual care, 3 were ineligible and the remaining 209 completed the study and were included in the analysis (mean [SD] age, 36.7 [12.4] years; 117 men [56.0%]; 187 [89.5%] positive for the human immunodeficiency virus). The primary outcome of in-hospital mortality occurred in 51 of 106 patients (48.1%) in the sepsis protocol group compared with 34 of 103 patients (33.0%) in the usual care group (between-group difference, 15.1% [95% CI, 2.0%-28.3%]; relative risk, 1.46 [95% CI, 1.04-2.05]; P = .03). In the 6 hours after presentation to the emergency department, patients in the sepsis protocol group received a median of 3.5 L (interquartile range, 2.7-4.0 L) of intravenous fluid compared with 2.0 L (interquartile range, 1.0-2.5 L) in the usual care group (mean difference, 1.2 L [95% CI, 1.0-1.5 L]; P < .001). Fifteen patients (14.2%) in the sepsis protocol group and 2 patients (1.9%) in the usual care group received vasopressors (between-group difference, 12.3% [95% CI, 5.1%-19.4%]; P < .001).

CONCLUSIONS AND RELEVANCE

Among adults with sepsis and hypotension, most of whom were positive for HIV, in a resource-limited setting, a protocol for early resuscitation with administration of intravenous fluids and vasopressors increased in-hospital mortality compared with usual care. Further studies are needed to understand the effects of administration of intravenous fluid boluses and vasopressors in patients with sepsis across different low- and middle-income clinical settings and patient populations.

TRIAL REGISTRATION

clinicaltrials.gov Identifier: NCT01663701.

摘要

重要性

早期复苏方案对发展中国家脓毒症结局的影响尚不清楚。

目的

确定与常规治疗相比,静脉输液、血管升压药和输血的早期复苏方案是否能降低赞比亚脓毒症和低血压成年患者的死亡率。

设计、地点和参与者:2012年10月22日至2013年11月11日期间,在赞比亚一家拥有1500张床位的转诊医院急诊科就诊的212例脓毒症(疑似感染加≥2项全身炎症反应综合征标准)和低血压(收缩压≤90mmHg或平均动脉压≤65mmHg)成年患者的随机临床试验。数据收集于2013年12月9日结束。

干预措施

患者按1:1随机分为两组:(1)脓毒症早期复苏方案组(n = 107),包括静脉推注液体,同时监测颈静脉压、呼吸频率和动脉血氧饱和度,并使用血管升压药将平均动脉压维持在≥65mmHg,以及对血红蛋白水平<7g/dL的患者进行输血;(2)常规治疗组(n = 105),由治疗医生确定血流动力学管理方案。

主要结局和指标

主要结局是住院死亡率,次要结局包括静脉输液量和血管升压药的使用情况。

结果

在212例随机接受脓毒症方案或常规治疗的患者中,3例不符合条件,其余209例完成研究并纳入分析(平均[标准差]年龄,36.7[12.4]岁;男性117例[56.0%];187例[89.5%]人类免疫缺陷病毒检测呈阳性)。脓毒症方案组106例患者中有51例(48.1%)发生住院死亡这一主要结局,而常规治疗组103例患者中有34例(33.0%)发生住院死亡(组间差异,15.1%[95%CI,2.0%-28.3%];相对风险,1.46[95%CI,1.04-2.05];P = 0.03)。在就诊于急诊科后的6小时内,脓毒症方案组患者静脉输液量中位数为3.5L(四分位间距,2.7-4.0L),而常规治疗组为2.0L(四分位间距,1.0-2.5L)(平均差异,1.2L[95%CI,1.0-1.5L];P < 0.)。脓毒症方案组15例患者(14.2%)和常规治疗组2例患者(1.9%)使用了血管升压药(组间差异,12.3%[95%CI,5.1%-19.4%];P < 0.001)。

结论和意义

在资源有限的环境中,对于大多数人类免疫缺陷病毒检测呈阳性的脓毒症和低血压成年患者,与常规治疗相比,静脉输液和血管升压药的早期复苏方案增加了住院死亡率。需要进一步研究以了解在不同低收入和中等收入临床环境及患者群体中,静脉推注液体和血管升压药对脓毒症患者的影响。

试验注册

clinicaltrials.gov标识符:NCT01663701。

相似文献

1
Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and Hypotension: A Randomized Clinical Trial.早期复苏方案对脓毒症和低血压成年患者院内死亡率的影响:一项随机临床试验
JAMA. 2017 Oct 3;318(13):1233-1240. doi: 10.1001/jama.2017.10913.
2
REstricted Fluid REsuscitation in Sepsis-associated Hypotension (REFRESH): study protocol for a pilot randomised controlled trial.脓毒症相关性低血压的限制性液体复苏(REFRESH):一项初步随机对照试验的研究方案
Trials. 2017 Aug 29;18(1):399. doi: 10.1186/s13063-017-2137-7.
3
Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial.疑似脓毒症相关性低血压患者的限制性液体复苏(REFRESH):一项先导随机对照试验。
Intensive Care Med. 2018 Dec;44(12):2070-2078. doi: 10.1007/s00134-018-5433-0. Epub 2018 Oct 31.
4
A randomized trial of protocol-based care for early septic shock.一项基于方案的早期脓毒性休克护理的随机试验。
N Engl J Med. 2014 May 1;370(18):1683-93. doi: 10.1056/NEJMoa1401602. Epub 2014 Mar 18.
5
Fluid Response Evaluation in Sepsis Hypotension and Shock: A Randomized Clinical Trial.脓毒症低血压和休克患者液体反应评估:一项随机临床试验。
Chest. 2020 Oct;158(4):1431-1445. doi: 10.1016/j.chest.2020.04.025. Epub 2020 Apr 27.
6
Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia.简化的严重脓毒症治疗方案:赞比亚改良早期目标导向治疗的随机对照试验
Crit Care Med. 2014 Nov;42(11):2315-24. doi: 10.1097/CCM.0000000000000541.
7
Resuscitation bundle compliance in severe sepsis and septic shock: improves survival, is better late than never.严重脓毒症和脓毒性休克中复苏集束化治疗的依从性:可提高生存率,亡羊补牢,为时未晚。
J Intensive Care Med. 2011 Sep-Oct;26(5):304-13. doi: 10.1177/0885066610392499. Epub 2011 Jan 10.
8
The Precision Resuscitation With Crystalloids in Sepsis (PRECISE) Trial: A Trial Protocol.《脓毒症晶体液精准复苏(PRECISE)试验:试验方案》。
JAMA Netw Open. 2024 Sep 3;7(9):e2434197. doi: 10.1001/jamanetworkopen.2024.34197.
9
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial.降低血管升压药暴露对老年血管舒张性低血压危重症患者90天死亡率的影响:一项随机临床试验
JAMA. 2020 Mar 10;323(10):938-949. doi: 10.1001/jama.2020.0930.
10
Patterns and Outcomes Associated With Timeliness of Initial Crystalloid Resuscitation in a Prospective Sepsis and Septic Shock Cohort.前瞻性脓毒症和脓毒性休克队列中初始晶体液复苏及时性相关的模式及结果
Crit Care Med. 2017 Oct;45(10):1596-1606. doi: 10.1097/CCM.0000000000002574.

引用本文的文献

1
Optimal time and volume of fluid resuscitation in patients with sepsis: a nationwide multicenter cohort study.脓毒症患者液体复苏的最佳时间和容量:一项全国性多中心队列研究。
Sci Rep. 2025 Aug 19;15(1):30465. doi: 10.1038/s41598-025-14854-8.
2
Association between the Venous Excess Ultrasound (VExUS) score and acute kidney injury in critically ill patients with sepsis: a multicenter prospective observational study.脓毒症重症患者静脉超声过量(VExUS)评分与急性肾损伤的相关性:一项多中心前瞻性观察研究
Ann Intensive Care. 2025 Jul 23;15(1):105. doi: 10.1186/s13613-025-01529-w.
3
Perceptions, availability and use of vasopressors for septic shock in emergency care settings in Tanzania.坦桑尼亚急诊护理环境中对脓毒性休克使用血管加压药的认知、可及性及使用情况
Afr J Emerg Med. 2025 Sep;15(3):100879. doi: 10.1016/j.afjem.2025.05.003. Epub 2025 Jun 2.
4
The Association Between Time to Completion of at Least 30 mL/kg and Hospital Outcomes Among Patients With Septic Shock.脓毒性休克患者至少完成30 mL/kg的时间与医院结局之间的关联
Crit Care Explor. 2025 Apr 28;7(5):e1253. doi: 10.1097/CCE.0000000000001253. eCollection 2025 May 1.
5
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill.重症监护中基于证据的个性化医疗:一种用于量化和应用重症患者个体化治疗效果的框架。
Lancet Respir Med. 2025 Jun;13(6):556-568. doi: 10.1016/S2213-2600(25)00054-2. Epub 2025 Apr 15.
6
Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.入住重症监护病房患者的生命支持使用情况及预后
JAMA. 2025 Apr 14. doi: 10.1001/jama.2025.2163.
7
The Effects of Passive Leg Raising and Maintenance Fluid Administration on Pulse Oximetry Waveform Amplitude and Peak Variability in Mechanically Ventilated Patients in Sepsis and Septic Shock.被动抬腿和维持液体输注对脓毒症和脓毒性休克机械通气患者脉搏血氧饱和度波形幅度及峰值变异性的影响
Diagnostics (Basel). 2025 Mar 21;15(7):798. doi: 10.3390/diagnostics15070798.
8
A narrative review of the pathophysiology of sepsis in sub-Saharan Africa: Exploring the potential for corticosteroid therapy.撒哈拉以南非洲地区脓毒症病理生理学的叙述性综述:探索皮质类固醇疗法的潜力。
PLOS Glob Public Health. 2025 Apr 9;5(4):e0004429. doi: 10.1371/journal.pgph.0004429. eCollection 2025.
9
European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients: part 2-the volume of resuscitation fluids.欧洲重症监护医学学会(ESICM)2025年成人危重症患者液体治疗临床实践指南:第2部分——复苏液体量
Intensive Care Med. 2025 Mar;51(3):461-477. doi: 10.1007/s00134-025-07840-1. Epub 2025 Mar 31.
10
"If We Manage Early, We Can Get It Right": A Descriptive Study of Healthcare Workers' Experiences Managing Sepsis at a Kenyan Referral Hospital.“若能早期管理,便可处置得当”:肯尼亚一家转诊医院医护人员管理脓毒症经历的描述性研究
Cureus. 2025 Feb 14;17(2):e78980. doi: 10.7759/cureus.78980. eCollection 2025 Feb.

本文引用的文献

1
Relationship between Mid-Upper Arm Circumference and Body Mass Index in Inpatients.住院患者上臂中部周长与体重指数之间的关系
PLoS One. 2016 Aug 5;11(8):e0160480. doi: 10.1371/journal.pone.0160480. eCollection 2016.
2
Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE.严重脓毒症和脓毒性休克的早期目标导向治疗:与ProCESS、ProMISe和ARISE研究的见解及比较
Crit Care. 2016 Jul 1;20(1):160. doi: 10.1186/s13054-016-1288-3.
3
Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock.多巴胺与肾上腺素治疗儿童感染性休克一线血管活性药物的双盲前瞻性随机对照试验。
Crit Care Med. 2015 Nov;43(11):2292-302. doi: 10.1097/CCM.0000000000001260.
4
Trial of early, goal-directed resuscitation for septic shock.早期目标导向性复苏治疗脓毒性休克的试验。
N Engl J Med. 2015 Apr 2;372(14):1301-11. doi: 10.1056/NEJMoa1500896. Epub 2015 Mar 17.
5
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study.拯救脓毒症运动:一项为期7.5年的研究中绩效指标与结果之间的关联
Crit Care Med. 2015 Jan;43(1):3-12. doi: 10.1097/CCM.0000000000000723.
6
Goal-directed resuscitation for patients with early septic shock.目标导向性复苏治疗早期感染性休克患者。
N Engl J Med. 2014 Oct 16;371(16):1496-506. doi: 10.1056/NEJMoa1404380. Epub 2014 Oct 1.
7
Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia.简化的严重脓毒症治疗方案:赞比亚改良早期目标导向治疗的随机对照试验
Crit Care Med. 2014 Nov;42(11):2315-24. doi: 10.1097/CCM.0000000000000541.
8
Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.2000-2012 年澳大利亚和新西兰重症监护病房严重脓毒症和脓毒性休克患者的死亡率。
JAMA. 2014 Apr 2;311(13):1308-16. doi: 10.1001/jama.2014.2637.
9
A randomized trial of protocol-based care for early septic shock.一项基于方案的早期脓毒性休克护理的随机试验。
N Engl J Med. 2014 May 1;370(18):1683-93. doi: 10.1056/NEJMoa1401602. Epub 2014 Mar 18.
10
Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense.中心静脉压能否预测液体反应性?一项更新的荟萃分析及对一些常识的呼吁。
Crit Care Med. 2013 Jul;41(7):1774-81. doi: 10.1097/CCM.0b013e31828a25fd.